1. Home
  2. PLAB vs ANIP Comparison

PLAB vs ANIP Comparison

Compare PLAB & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLAB
  • ANIP
  • Stock Information
  • Founded
  • PLAB 1969
  • ANIP 2001
  • Country
  • PLAB United States
  • ANIP United States
  • Employees
  • PLAB N/A
  • ANIP N/A
  • Industry
  • PLAB Semiconductors
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLAB Technology
  • ANIP Health Care
  • Exchange
  • PLAB Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • PLAB 1.3B
  • ANIP 1.2B
  • IPO Year
  • PLAB 1987
  • ANIP N/A
  • Fundamental
  • Price
  • PLAB $17.67
  • ANIP $69.21
  • Analyst Decision
  • PLAB Strong Buy
  • ANIP Strong Buy
  • Analyst Count
  • PLAB 1
  • ANIP 8
  • Target Price
  • PLAB $35.00
  • ANIP $79.75
  • AVG Volume (30 Days)
  • PLAB 823.0K
  • ANIP 423.7K
  • Earning Date
  • PLAB 05-21-2025
  • ANIP 05-09-2025
  • Dividend Yield
  • PLAB N/A
  • ANIP N/A
  • EPS Growth
  • PLAB 5.99
  • ANIP N/A
  • EPS
  • PLAB 2.35
  • ANIP N/A
  • Revenue
  • PLAB $862,750,000.00
  • ANIP $614,376,000.00
  • Revenue This Year
  • PLAB $2.60
  • ANIP $27.62
  • Revenue Next Year
  • PLAB $6.56
  • ANIP $7.71
  • P/E Ratio
  • PLAB $7.52
  • ANIP N/A
  • Revenue Growth
  • PLAB N/A
  • ANIP 26.20
  • 52 Week Low
  • PLAB $16.46
  • ANIP $52.50
  • 52 Week High
  • PLAB $31.60
  • ANIP $70.18
  • Technical
  • Relative Strength Index (RSI)
  • PLAB 37.21
  • ANIP 60.35
  • Support Level
  • PLAB $17.29
  • ANIP $61.43
  • Resistance Level
  • PLAB $18.50
  • ANIP $68.82
  • Average True Range (ATR)
  • PLAB 1.07
  • ANIP 3.38
  • MACD
  • PLAB -0.08
  • ANIP -0.00
  • Stochastic Oscillator
  • PLAB 27.82
  • ANIP 85.97

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz or glass plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue world-wide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: